Investors

Advanced Neuromodulation Systems (ANS) became a division of St. Jude Medical (www.sjm.com) in a merger that was completed in the fourth quarter of 2005. St. Jude Medical’s acquisition of ANS taps the enormous potential of the rapidly growing, billion dollar neuromodulation market and expands St. Jude’s implantable microelectronics technology program.

St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The company has five major focus areas that include: neuromodulation, cardiac rhythm management, atrial fibrillation, cardiac surgery, and cardiology. Headquartered in St. Paul, Minnesota, the company employs approximately 10,000 people worldwide.

For St. Jude Medical investor information, please click here. For more information about ANS, visit About ANS or News Room sections of this site.